Article

Tracking Transmitted HIV Drug Resistance in a Rural Southern Community

Author(s):

Transmitted HIV drug resistance is a growing problem. Researchers found 20% of treat-naive HIV patients in a rural Southern US community had such transmitted drug resistant strains of the virus.

Patients with HIV who develop drug resistance can transmit their strains to others.

In a study presented at IDWeek 2016 in New Orleans, LA, researchers discussed their retrospective study of transmitted drug resistance (TDR) in a rural Southern US county.

Ahmed Abubaker, MD, an infectious disease specialist at East Carolina University in Greenville, NC and colleagues conducted a study of all newly diagnosed HIV patients who had not been getting antiretroviral therapy. They collected demographic information, lab results including CD4 counts, viral load, and HIV genotype.

They noted whether transmitted drug resistance was present as well as individual mutations in the virus.

There were 210 patients whose charts were part of the study.

Forty-five were excluded for various reasons including unavailable genotype results.

They found the prevalence of TDR was 20% overall.

Gender, race and county of residence were not associated with the presence of TDR but being younger than 25 and being an man who had sex with men was found to be a common risk factor.

The concluded that “targeted infection prevention programs are needed in order to limit the further spread of resistant HIV-1 in this population in eastern North Carolina.”

Related Coverage:

Resistance to Common HIV Treatment Persists Worldwide

Database Can Find New HIV Hotspots

Related Videos
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia
Corinna L. Schultz, MD: Improving Sickle Cell Trait Documentation in Infancy
Sibgha Zaheer, MD: Determining Washout Period With Fitusiran, Emicizumab Transition for Hemophilia
Pavan K. (Tem) Bendapudi, MD: Large-Scale Analyses Elucidate Genetic Risk of Thrombosis
Seema Rani, MD: Examining Sleep Health in Youth With SCD
Daniel Wang: A More Appropriate Ferritin Threshold is Cost-Effective for Iron Deficiency Screening
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
© 2025 MJH Life Sciences

All rights reserved.